Regeneron
Aftab Alam is an experienced professional in market access strategy within the biopharmaceutical industry. Currently serving as the Senior Director U.S. Market Access Strategy Lead for Hematology at Regeneron since July 2019, Aftab is responsible for developing comprehensive market access strategies. Prior to this role, Aftab held positions at AstraZeneca and Genentech, including Director of U.S. Market Access Strategy for Ophthalmology and Associate Director of Market Access Strategy for Immunology. Aftab's career began at Merck, where multiple roles included Cardiovascular Specialty Sales Territory Manager. Aftab holds a Bachelor of Arts in Biology and Chemistry from Case Western Reserve University.
This person is not in any teams
This person is not in any offices